Arkolith/Insider Trading/PTCT/Form 4

Boulding Mark Elliott

EXEC. VP AND CLOPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed Jun 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$823K
Net Open-Market Flow
-$823K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)9K$46.54$396K114K
Jun 17, 2026Sell(S)7K$78.50$518K107K
Jun 17, 2026Sell(S)2K$79.24$147K105K
Jun 17, 2026Option exercise(M)2K$46.54$94K107K
Jun 17, 2026Sell(S)2K$78.50$134K106K
Jun 17, 2026Sell(S)309$79.25$24K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)9K—$033K
Jun 17, 2026Option exercise(M)2K—$031K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578852-26-000018) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML